Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for pediatric general anesthesia (PPK, safety and efficacy)
CTR20210920Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esketamine, sponsored by Hengrui Therapeutics. Started May 2021; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on CTR20210920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210920.